BAUMGARTNER ROBERT V 4
4 · BIO-TECHNE Corp · Filed Nov 1, 2021
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
BAUMGARTNER ROBERT V
Director
Transactions
- Award
Common Stock
2021-10-28+194→ 9,806 total - Award
Stock Options (right to buy)
2021-10-28+633→ 633 totalExercise: $515.24Exp: 2031-10-28→ Common Stock (633 underlying)
Holdings
- 3,125
Stock Options (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 2,011
Stock Options (right to buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying) - 1,507
Stock Options (right to buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying) - 4,260
Stock Options (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 1,898
Stock Options (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 4,000
Stock Options (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 3,985
Stock Options (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders.